Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers



  Free Subscription

Articles published in AIDS

Retrieve available abstracts of 26 articles:
HTML format

Single Articles

    December 2019
  1. MCHEMBERE W, Agaya J, Yuen CM, Okelloh D, et al
    High yield of new HIV diagnoses during active case-finding for tuberculosis.
    AIDS. 2019;33:2431-2435.
    PubMed     Abstract available

  2. MUPFUMI L, Moyo S, Shin SS, Wang Q, et al
    High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015.
    AIDS. 2019;33:2415-2422.
    PubMed     Abstract available

    November 2019
  3. MEYERS T, Samson P, Acosta EP, Moye J, et al
    Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis.
    AIDS. 2019;33:2197-2203.
    PubMed     Abstract available

    October 2019
  4. CHAISSON LH, Saraceni V, Cohn S, Seabrook D, et al
    CD4 count stratification to guide tuberculosis preventive therapy for people living with HIV.
    AIDS. 2019 Oct 11. doi: 10.1097/QAD.0000000000002398.
    PubMed     Abstract available

    September 2019
  5. KENDALL EA, Durovni B, Martinson NA, Cavalacante S, et al
    Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002380.
    PubMed     Abstract available

  6. MUPFUMI L, Moyo S, Shin SS, Wang Q, et al
    High Incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National ART programme between 2011 and 2015.
    AIDS. 2019 Sep 3. doi: 10.1097/QAD.0000000000002363.
    PubMed     Abstract available

    August 2019
  7. MCHEMBERE W, Agaya J, Yuen CM, Okelloh D, et al
    High yield of new HIV diagnoses during active case-finding for tuberculosis.
    AIDS. 2019 Aug 22. doi: 10.1097/QAD.0000000000002354.
    PubMed     Abstract available

    May 2019
  8. SOVERSHAEVA E, Kranzer K, Mchugh G, Bandason T, et al
    History of tuberculosis is associated with lower exhaled nitric oxide levels in HIV-infected children.
    AIDS. 2019 May 11. doi: 10.1097/QAD.0000000000002265.
    PubMed     Abstract available

    March 2019
  9. WEARNE N, Hung R, Bohmer R, Spies R, et al
    Kidney disease in africans with hiv and tuberculosis.
    AIDS. 2019 Mar 19. doi: 10.1097/QAD.0000000000002204.
    PubMed     Abstract available

    January 2019
  10. CHAISSON LH, Semitala FC, Asege L, Mwebe S, et al
    Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.
    AIDS. 2019 Jan 14. doi: 10.1097/QAD.0000000000002130.
    PubMed     Abstract available

    October 2018
  11. KENDALL EA, Azman AS, Maartens G, Boulle A, et al
    Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden setting.
    AIDS. 2018 Oct 15. doi: 10.1097/QAD.0000000000002053.
    PubMed     Abstract available

  12. SUDFELD CR, Buchanan A, Ulenga N, Spiegelman D, et al
    Effectiveness of a multivitamin supplementation program among HIV-infected adults in Tanzania.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002033.
    PubMed     Abstract available

    September 2018
  13. MZEMBE T, Mclean E, Khan PY, Koole O, et al
    Risk of Mycobacterium tuberculosis transmission in an antiretroviral therapy clinic.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002006.
    PubMed     Abstract available

    August 2018
  14. RHINES AS, Feldman MW, Bendavid E
    Modeling the implementation of population-level isoniazid preventive therapy for tuberculosis control in a high HIV-prevalence setting.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001959.
    PubMed     Abstract available

    July 2018
  15. WORODRIA W, Ssempijja V, Hanrahan C, Ssegonja R, et al
    Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ counts.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001941.
    PubMed     Abstract available

    May 2018
  16. SHAPIRO AE, Hong T, Govere S, Thulare H, et al
    C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa.
    AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001902.
    PubMed     Abstract available

    March 2018
  17. KROEZE S, Ondoa P, Kityo CM, Siwale M, et al
    Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001801.
    PubMed     Abstract available

    October 2017
  18. LACOURSE SM, Pavlinac PB, Cranmer LM, Njuguna IN, et al
    Stool Xpert MTB/RIF and urine lipoarabinomannan (LAM) for diagnosing tuberculosis in hospitalized HIV-infected children.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001662.
    PubMed     Abstract available

    August 2017
  19. WINTER JR, Stagg HR, Smith CJ, Brown AE, et al
    Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV from 2000 to 2014.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001635.
    PubMed     Abstract available

    July 2017
  20. BISSON GP, Ramchandani R, Miyahara S, Mngqibisa R, et al
    Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.
    AIDS. 2017 Jul 24. doi: 10.1097/QAD.0000000000001606.
    PubMed     Abstract available

    June 2017
  21. LECCA L, Galea J, Contreras CC, Millones AK, et al
    Challenges in tuberculosis/HIV management in a country with a concentrated HIV epidemic.
    AIDS. 2017;31:1207-1209.

    January 2017

  22. One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.
    AIDS. 2017;31:375-384.
    PubMed     Abstract available

    November 2016
  23. KUNKEL A, Crawford FW, Shepherd J, Cohen T, et al
    Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.
    AIDS. 2016;30:2715-2723.
    PubMed     Abstract available

    October 2016
  24. VAN DER WERF MJ, Kodmon C, Zucs P, Hollo V, et al
    Tuberculosis and HIV co-infection in Europe: looking at one reality from two angles.
    AIDS. 2016.
    PubMed     Abstract available

    August 2016
  25. ALVAREZ H, Marino A, Garcia-Rodriguez JF, Vilas-Sueiro A, et al
    Immune reconstitution inflammatory syndrome in an HIV-infected patient using subcutaneous silicone fillers.
    AIDS. 2016.
    PubMed     Abstract available

    January 2016
  26. MARAIS S, Meintjes G, Lesosky M, Wilkinson KA, et al
    Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis.
    AIDS. 2016;30:395-404.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.